Literature DB >> 29209787

[Different levels of experience with anesthetic agents of German emergency physicians : Results of an online survey].

A Luckscheiter1, M Fischer2, W Zink3.   

Abstract

BACKGROUND AND
OBJECTIVE: In 2015 practice management guidelines on prehospital emergency anesthesia in adults were published in Germany. The aim of the present study was to evaluate whether emergency physicians follow these guidelines in daily practice and to assess their level of experience with the use of anesthetic agents.
MATERIAL AND METHODS: In an online survey the way of induction of preclinical anesthesia (including preoxygenation time and applied monitoring techniques) was assessed with the help of virtual scenarios based on the guidelines. Furthermore, the individual level of experience with specific anesthetic agents was estimated by the total number of anesthetic procedures performed with these drugs (0, 1-10, 11-25, 26-50, 51-100, and >100 procedures). RESULT: A total of 155 emergency physicians answered the online survey. Except for cardiac patients and for the preoxygenation time, we found a high accordance between specific algorithms proposed in the guidelines and emergency physicians' clinical practice. Furthermore, the median level of experience with rocuronium and succinylcholine was significantly higher compared to vecuronium. With respect to induction agents the highest level of experience was found for propofol and thiopental, the lowest for the combination of ketamine/propofol and midazolam. Generally, compared to non-anesthetists, emergency physicians had significantly higher levels of experience with the use of these anesthetic agents (except for etomidate and vecuronium). Over 94% used a 4-lead electrocardiogram (ECG), pulse oxymetry, non-invasive blood pressure and quantitative capnography for monitoring. The availability of succinylcholine was 91%, rocuronium 55%, vecuronium 29% and sugammadex 9%.
CONCLUSION: The results of this survey demonstrate that clinical practice of emergency physicians is in high accordance with the recommendations named in the guidelines for prehospital emergency anesthesia in adults (except for cardiac patients and time of preoxygenation). With respect to the lower levels of experience of non-anesthetists in the use of anesthetic drugs, specific training concepts may help to further improve the quality of preclinical emergency care.

Entities:  

Keywords:  Anesthetics; Emergency medicine; General anesthesia; Neuromuscular blocking agents

Mesh:

Substances:

Year:  2017        PMID: 29209787     DOI: 10.1007/s00101-017-0386-1

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  14 in total

1.  [Stocked medications in emergency physician-based medical services in Germany. Reality and requirements according to guidelines].

Authors:  D Rörtgen; A Schaumberg; M Skorning; S Bergrath; S K Beckers; M Coburn; J C Brokmann; H Fischermann; M Nieveler; R Rossaint
Journal:  Anaesthesist       Date:  2010-12-04       Impact factor: 1.041

2.  [Airway management in intensive care units in Rhineland-Palatinate : Evolution over five years].

Authors:  T Piepho; T Härer; L Ellermann; R R Noppens
Journal:  Anaesthesist       Date:  2017-02-13       Impact factor: 1.041

3.  The out-of-hospital esophageal and endobronchial intubations performed by emergency physicians.

Authors:  Arnd Timmermann; Sebastian G Russo; Christoph Eich; Markus Roessler; Ulrich Braun; William H Rosenblatt; Micheal Quintel
Journal:  Anesth Analg       Date:  2007-03       Impact factor: 5.108

4.  The who, where, and what of rapid sequence intubation: prospective observational study of emergency RSI outside the operating theatre.

Authors:  C Reid; L Chan; M Tweeddale
Journal:  Emerg Med J       Date:  2004-05       Impact factor: 2.740

5.  Incidence of transient hypoxia and pulse rate reactivity during paramedic rapid sequence intubation.

Authors:  James V Dunford; Daniel P Davis; Mel Ochs; Michael Doney; David B Hoyt
Journal:  Ann Emerg Med       Date:  2003-12       Impact factor: 5.721

Review 6.  [Rocuronium and sugammadex in emergency medicine: requirements of a muscle relaxant for rapid sequence induction].

Authors:  J Luxen; H Trentzsch; B Urban
Journal:  Anaesthesist       Date:  2014-04       Impact factor: 1.041

7.  Safety of Propofol as an Induction Agent for Urgent Endotracheal Intubation in the Medical Intensive Care Unit.

Authors:  Seth J Koenig; Viera Lakticova; Mangala Narasimhan; Peter Doelken; Paul H Mayo
Journal:  J Intensive Care Med       Date:  2014-02-17       Impact factor: 3.510

Review 8.  Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients.

Authors:  Eric A Bruder; Ian M Ball; Stacy Ridi; William Pickett; Corinne Hohl
Journal:  Cochrane Database Syst Rev       Date:  2015-01-08

9.  AAGBI: Safer pre-hospital anaesthesia 2017: Association of Anaesthetists of Great Britain and Ireland.

Authors:  D J Lockey; K Crewdson; G Davies; B Jenkins; J Klein; C Laird; P F Mahoney; J Nolan; A Pountney; S Shinde; S Tighe; M Q Russell; J Price; C Wright
Journal:  Anaesthesia       Date:  2017-01-03       Impact factor: 6.955

10.  (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.

Authors:  Julia Höfler; Alexandra Rohracher; Gudrun Kalss; Georg Zimmermann; Judith Dobesberger; Georg Pilz; Markus Leitinger; Giorgi Kuchukhidze; Kevin Butz; Alexandra Taylor; Helmut Novak; Eugen Trinka
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

View more
  2 in total

1.  [Performance of prehospital emergency anesthesia and airway management : An online survey].

Authors:  T Warnecke; M Dobbermann; T Becker; M Bernhard; J Hinkelbein
Journal:  Anaesthesist       Date:  2018-06-29       Impact factor: 1.041

2.  [Preclinical emergency anesthesia : A current state analysis from 2015-2017].

Authors:  A Luckscheiter; T Lohs; M Fischer; W Zink
Journal:  Anaesthesist       Date:  2019-03-18       Impact factor: 1.041

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.